Lecture Notes

**Lecture Coverage:**
- Rheumatoid Arthritis
- NSAIDs
- Slow Acting Anti-Rheumatic Drugs (SAARDs)
- Glucocorticoids
- New Antirheumatic Drugs

---
#### **Rheumatoid Arthritis**
- Synovitis from Immunoresponse against Joint Tissue
	- Severe joint stiffness, swelling & deformities with pain
    - Through Pro-Inflammatory cytokines:
	    - IL-1/2
	    - TNF-α
- Causes:
	- Genetic
	- Environmental Factors
	- Acute Trigger (Trauma / Infection)
- Treatment Aim:
	- Symptom Relief
	- Lifestyle Preservation
	- Prevention of Structural Damage & Dysfunction


#### **NSAIDs**
- Pain Relief Only ([[Lecture 8.1 - Pain & Analgesics#**Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)**|Mechanism]])
	- Need Higher Dose & Longer Duration than Simple Analgesia
		- High chance of side effects (esp. GI)
		- Paracetamol: Less side effect risk but very weak anti-inflammatory effect
- Does not Alter Disease Course


#### **Slow Acting Anti-Rheumatic Drugs (SAARDs)**
**Advantages & Disadvantages of SAARDs**
- Advantages:
	- May retard disease progress
	- Beneficial in Progressive RA 
		- ∵ Poor response to NSAIDs
	- ↓ Pain & Swelling
- Disadvantages:
	- Does not completely halt RA
	- Slow-Acting: ~6 Weeks before Improvement is shown
	- Side Effects:
		- Immunodeficiency
		- Hyperglycemia & Dyslipidemia → Hypertension
		- Peptic, Liver & Kidney Injury

**Hydroxychloroquine**
- ↓ Production of Pro-inflammatory Cytokines
	- Different actions on different leukocytes:

|   Cell Type    |                        Role                         |  Significance  |
| :------------: | :-------------------------------------------------: | :------------: |
| <br>T & B Cell |                    ↓ Activation                     |       <        |
|       ^        |      T<sub>reg</sub>/Th17 Cell Ratio Balancing      |       <        |
|      APC       |               ↓ Antigen Presentation                |       <        |
|   Neutrophil   | ↓ <abbr Title="NADPH Oxidase">NOX</abbr> Signalling | ↓ Phagocytosis |

**Sulphasalasine**
- Prodrug that splits into 2 Parts:
	- Sulphapyridine
		- Anti-bacterial
		- ↓ NK-Cell Immunoresponses
	- 5-Amino-Salicylic Acid
		- Salicylate (COX Inhibitor)

**Methotrexates (MTX)**
- Oral / Injection
- Inhibitor of several nucleotide synthesis enzymes
	- Suppress Mitosis & Inflammation
	- Different actions in different leukocytes:

|            Cell Type            |                                              Role                                               |                                                   Significance                                                   |
| :-----------------------------: | :---------------------------------------------------------------------------------------------: | :--------------------------------------------------------------------------------------------------------------: |
|           <br>T Cell            |         ↑ <abbr Title="Long Intergenic Non-Coding RNA-21">lincRNA-21</abbr> Expression          |                                                        <                                                         |
|                ^                |                   <abbr Title="Dihydrofolate Reductase">DHFR</abbr> Inhibitor                   | ↓ <abbr Title="Dihydrobiopterin">BH<sub>2</sub></abbr> → <abbr Title="Tetrahydrobiopterin">BH<sub>4</sub></abbr> |
|            Monocyte             |                   <abbr Title="Dihydrofolate Reductase">DHFR</abbr> Inhibitor                   |               ↓ <abbr Title="Dihydrofolate">DHF</abbr> → <abbr Title="Tetrahydrofolate">TTF</abbr>               |
| Fibroblast-Like<br>Synoviocytes | <abbr Title="Aminoimidazole-4-Carboxamide Ribonucleotide">AICAR</abbr> Transformylase Inhibitor |           ↑ Intracellular AICAR<br>↑ <abbr Title="Anti-Inflammatory Mediator">Adenosine</abbr> Release           |

**Leflunomide**
- Converted to A771726

| Cell Type |                                Role                                | Significance                                                                                               |
| :-------: | :----------------------------------------------------------------: | :--------------------------------------------------------------------------------------------------------- |
|  T  Cell  | <abbr Title="Dihydroorotate Dehydrogenase">DHODH</abbr> Inhibition | ↓ <abbr Title="C, U, T in DNA">Pyrimidine</abbr> Production<br>→ ↓ DNA Production for T Cell Proliferation |


#### **Glucocorticoids**
**Mechanism of Glucocorticoid Action**
- ↓ Chronic Inflammation & Autoimmune Reactions

| Step  | Event                                                                                                           |
| :---: | --------------------------------------------------------------------------------------------------------------- |
|   1   | Bind to Receptor & Form Steroid-Receptor Complex                                                                |
|   2   | Complex Dimerizes → Travel to DNA                                                                               |
| <br>3 | ↓ COX-2 Gene Transcription → ↓ PGE<sub>2</sub> & PGI<sub>2</sub> → ↓ Vasodilation                               |
|   ^   | ↓ Leukocyte Gene Transcription → ↓ Clonal Expansion of B & T Cells                                              |
|   ^   | ↑ <abbr Title="PLA₂ Inhibitor">Annexin-A1</abbr> Release → ↑ PLA<sub>2</sub> Inhibition → ↓ Pro-Inflammatory PG |

**Examples of Glucocorticoids**
- Cortisol
- Prednisolone
	- Used in RA when other treatment fails
	- Oral / Injection

**Side Effects of Glucocorticoids**
- Suppression of Protective Inflammatory Responses
	- ↑ Opportunistic Infection
- Osteoporosis
- <abbr Title="Drug-Induced">Iatrogenic</abbr> Cushing's Syndrome


#### **New Antirheumatic Drugs**
**Anti-cytokine Drugs**
- Targets: 
	- IL-1,2 
	- TNF-α

| **Drugs**                                                                    | **Description**                                          |
| ---------------------------------------------------------------------------- | -------------------------------------------------------- |
| Basilixi<font color="cyan">mab</font> & Daclizu<font color="cyan">mab</font> | IL-2 Receptor α-chain <font color="cyan">Antibody</font> |
| Inflixi<font color="cyan">mab</font> & Adalimu<font color="cyan">mab</font>  | TNF-α <font color="cyan">Antibody</font>                 |
| Anakinra                                                                     | IL-1 Receptor Antagonist                                 |
| Etanercept                                                                   | Soluble TNF-α Receptor Antagonist                        |

**Lymphocyte Blockers**

| **Drugs**                             | **Description**                                                                     |
| ------------------------------------- | ----------------------------------------------------------------------------------- |
| Rituxima<font color="red">b</font>    | ↑ <font color="red">B</font> Cell Senescence & Apoptosis                            |
| Abatacep<font color="yellow">t</abbr> | ↓ <font color="yellow">T</font> cell Co-stimulation<br>∵ Binds to B7 protein on APC |
